Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Norton J. Greenberger"'
Autor:
Ophelia Yin, Francesco Nordio, Sabina A. Murphy, Elliott M. Antman, Laura T. Grip, Norton J. Greenberger, Arman Qamar, Hans Lanz, Michele Mercuri, Eugene Braunwald, Youngsook Choi, Christian T. Ruff, Robert P. Giugliano
Publikováno v:
Journal of the American College of Cardiology. 74:179-189
Background Patients with liver disease have increased risk of thrombosis and bleeding but are typically excluded from trials of direct oral anticoagulant agents. Objectives This study evaluated the pharmacokinetics (PK), pharmacodynamics (PD), clinic
Publikováno v:
Journal of the American College of Cardiology. 71(19)
Patients with liver disease are at increased risks of both thrombotic and bleeding complications. Many have atrial fibrillation (AF) or venous thromboembolism (VTE) necessitating oral anticoagulant agents (OACs). Recent evidence has contradicted the
Autor:
Norton J. Greenberger
Publikováno v:
Schiff's Diseases of the Liver, Eleventh Edition
Autor:
Norton J. Greenberger, Amir A. Qamar
Publikováno v:
DeckerMed Neurology.
Hepatic encephalopathy, also referred to as portosystemic encephalopathy (PSE), is a complex neuropsychiatric disorder resulting from chronic parenchymal liver disease or liver failure, often in conjunction with portosystemic shunts, either naturally
Autor:
Norton J. Greenberger
This chapter provides review topics in Gastroenterology and Hepatology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c065b9e141362fa46b867378d6b22234
https://doi.org/10.1093/med/9780199358274.003.0076
https://doi.org/10.1093/med/9780199358274.003.0076
Autor:
Christina Stahre, Nayyar Iqbal, Markus M. Lerch, KyungAh Im, Ofri Mosenzon, Norton J. Greenberger, Alona Buskila, Boaz Hirshberg, Itamar Raz, Amarachi A. Umez-Eronini, Deepak L. Bhatt, Benjamin M. Scirica
Publikováno v:
Diabetes care. 37(9)
OBJECTIVE To determine the incidence of pancreatitis and pancreatic cancer in the SAVOR-TIMI 53 trial. RESEARCH DESIGN AND METHODS A total of 16,492 type 2 diabetic patients ≥40 years old with established cardiovascular (CV) disease or CV risk fact
Autor:
Norton J. Greenberger, D. O. Castell
Publikováno v:
Hospital Practice. 34:89-98
Heartburn and other symptoms of gastroesophageal reflux disease can be a lifelong problem, affecting millions of Americans each year. Fortunately, treatment has improved dramatically over the past decade. Medications currently available are remarkabl
Autor:
Norton J. Greenberger
Publikováno v:
Gastroenterology Clinics of North America. 28:687-693
Pancreatic enzyme replacement therapy has proved useful in the treatment of malabsorption and persistent pain in patients with chronic pancreatitis. The formulation of pancreatic enzyme preparation varies considerably. Treatment of chronic pain is fa
Publikováno v:
Hospital Practice. 34:77-94
Recognizing clinical and pathologic scenarios, rather than ordering definitive tests, is still the basis for diagnosis of Crohn's disease. Steroids, salicylates, immunomodulating agents, and surgery remain the focus of treatment. The advent of inflix
Publikováno v:
Hospital Practice. 33:43-62
The nausea and vomiting that can complicate advanced diabetes is often attributed to impaired gastric motility. Not all patients with diabetic gastropathy show marked abnormality on gastric emptying studies, however. The mechanism remains uncertain,